Year: 2021

Sanoma Corporation – Acquisition of own shares on 10 November 2021

Written by Customer Service on November 10, 2021. Posted in Public Companies.

SANOMA CORPORATION, STOCK EXCHANGE RELEASE, 10 November 2021 at 19:00 EET Sanoma Corporation – Acquisition of own shares on 10 November 2021 At Nasdaq Helsinki Ltd:Date 10 November 2021Exchange transaction BuyShare trading code SAA1VAmount, shares 17,000Average price/share, EUR 14.288Total cost, EUR 242,896.00The company holds a total of 353,614 of its own shares (SAA1V) including the shares acquired on 10 November 2021. Detailed information concerning the acquisition is attached to this stock exchange release. On behalf of Sanoma Corporation DANSKE BANK A/S, FINLAND BRANCH Jonathan Nyberg Antti Väliaho Additional information Kaisa Uurasmaa, Head of Investor Relations and Sustainability, tel. +358 40 560 5601 Sanoma Sanoma is an innovative and agile learning and media company impacting the lives of millions...

Pharmagest Interactive: 2021 third-quarter revenue

Written by Customer Service on November 10, 2021. Posted in Public Companies.

Villers-lès-Nancy, 10 November 2021 – 6:00 p.m. (CET) PRESS RELEASE 2021 third-quarter revenue Steady in Q3 2021 at €44.21m and up 12.96% for the first nine months to €138.11m:Significant contributions from acquisitions (+€7.91m) on a 9-month basis: PANDALAB, ASCA INFORMATIQUE, PHARMAGEST SERVIZI, ATHESIA. Like-for-like, growth of 6.49% to €130.21m.Full-year revenue targets for 2021 confirmed.In €m 2019 2020 2021 Change2021/2019 Change2021/2020Q1 38.15 39.00 45.27 + 18.68 % + 16.09 %Q2 38.73 38.93 48.63 + 25.55 % + 24.90 %Q3 (unaudited) 35.28 44.34 44.21 + 25.34 % – 0.29 %9 month YTD 112.16 122.27 138.11 + 23.15% + 12.96 %In Q3 2021, Pharmagest Group had unaudited consolidated sales of €44.21m, remaining steady in relation to the same quarter in the prior year (unfavourable...

TransGlobal Assets Inc. (TMSH) Granted Hemp Grower Registration For Its South Haven Property

Written by Customer Service on November 10, 2021. Posted in Public Companies.

$TMSH – TransGlobal Assets Inc. (TMSH) Granted Hemp Grower Registration For Its South Haven PropertyHemp Grower RegistrationPittsburgh, PA, Nov. 10, 2021 (GLOBE NEWSWIRE) — TransGlobal Assets, Inc. (OTC PINK: TMSH) is pleased to announce the State of Michigan has registered the company as a Hemp Grower for its South Haven property. The registration is an important milestone in The Hemp Ranch development project. The company has plans to begin Hemp production in the spring of 2023 which will be when construction has been finished. The Company has allocated 10 acres exclusively for outdoor Hemp cultivation and new CBD strain development. This area is not only designated for Hemp growing but it will also be used for educational tours offering a hands-on experience into the science of Hemp cultivation. The Company...

FLSmidth appoints Mikko Keto as new Group CEO

Written by Customer Service on November 10, 2021. Posted in Public Companies.

Mikko KetoMikko Keto, CEO FLSmidthCompany announcement 16-2021, COPENHAGEN, DENMARK Thomas Schulz, FLSmidth’s Group CEO, has made the decision to take a role outside of the company, and will therefore step down as FLSmidth’s CEO by end of 2021. Mikko Keto, who joined FLSmidth in January 2021 as President of FLSmidth’s Mining business and member of Group Executive Management, has been appointed incoming CEO by FLSmidth’s Board of Directors, effective 1 January 2022. Vagn Sørensen, Chairman, states: “I am pleased we are able to recruit internally for such a vital position, which will ensure a continuation of the strong progress FLSmidth is demonstrating. Since joining FLSmidth, Mikko has been setting a clear direction for our Mining business and is overseeing the thyssenkrupp acquisition’s* integration planning. There is...

Ramsay Sante : quarterly accounts at the end of September 2021

Written by Customer Service on November 10, 2021. Posted in Earnings Releases And Operating Results.

PRESS RELEASEParis, 10 November 2021 A continued positive development in the Nordics but a more complicated than expected recovery in business in France due to a fourth wave of Covid, and staff challengesUnaudited turnover for the three months period ending 30 September 2021 amounted to €936.4m up 2% on a reported basis; Unaudited EBITDA for the three months period ending 30 September 2021 amounted to €135.1m down -18% on a reported basis; Unaudited current operating profit for the three months period ending 30 September 2021 amounted to €43.5m down -39% on a reported basis; Historically performance in Q1 is lower than Q2 following the summer period in Q1 – last year this was the opposite due to the catch-up of volumes post the first COVID lockdown in France and then Q2 last year was heavily impacted by the second COVID wave; Total...

Suominen Corporation: SHARE REPURCHASE 10.11.2021

Written by Customer Service on November 10, 2021. Posted in Public Companies.

Suominen Corporation ANNOUNCEMENT 10.11.2021 Suominen Corporation: SHARE REPURCHASE 10.11.2021 In the Helsinki Stock Exchange Trade date 10.11.2021 Bourse trade Buy Share SUY1V Amount 9,000 SharesAverage price/ share 4.9952 EURTotal cost 44,956.80 EUR Suominen Corporation now holds a total of 674 561 sharesincluding the shares repurchased on 10.11.2021 On behalf of Suominen Corporation Nordea Bank Oyj Janne Sarvikivi Sami Huttunen For additional information, please contact: Toni Tamminen, CFO, Suominen Corporation tel. +358 (0)10 214 3051 www.suominen.fi AttachmentSuominen 10.11 trades

Innofactor Plc: Share Repurchase 10.11.2021

Written by Customer Service on November 10, 2021. Posted in Public Companies.

Innofactor Plc ANNOUNCEMENT 10.11.2021 INNOFACTOR PLC: SHARE REPURCHASE 10.11.2021 In the Helsinki Stock Exchange Trade date 10.11.2021 Bourse trade Buy Share IFA1V Amount 24,000 SharesAverage price/ share 1.5592 EURTotal cost 37,420.80 EUR Innofactor Plc now holds a total of 226 000 sharesincluding the shares repurchased on 10.11.2021 On behalf of Innofactor Plc Nordea Bank Oyj Janne Sarvikivi Sami Huttunen Additional information: Sami Ensio, CEO Innofactor Plc Tel. +358 50 584 2029 sami.ensio@innofactor.com www.innofactor.com AttachmentInnofactor_10.11_trades

Uponor Corporation: SHARE REPURCHASE 10.11.2021

Written by Customer Service on November 10, 2021. Posted in Public Companies.

Uponor Corporation ANNOUNCEMENT 10.11.2021 Uponor Corporation: SHARE REPURCHASE 10.11.2021 In the Helsinki Stock Exchange Trade date 10.11.2021 Bourse trade Buy Share UPONOR Amount 26,519 SharesAverage price/ share 21.1834 EURTotal cost 561,762.58 EUR Uponor Corporation now holds a total of 347 671 sharesincluding the shares repurchased on 10.11.2021 On behalf of Uponor Corporation Nordea Bank Oyj Janne Sarvikivi Sami Huttunen For more information, please contact: Uponor Corporation Susanna Inkinen Vice President, Communications and Corporate ResponsibilityTel. +358 20 129 2081 www.uponorgroup.com AttachmentUponor_10.11_trades ...

Hybrid Software Group PLC: Notification of transactions in shares by persons discharging managerial responsibility

Written by Customer Service on November 10, 2021. Posted in Public Companies.

PRESS RELEASE – REGULATED INFORMATION Notification of transactions in shares by persons discharging managerial responsibility (“PDMRs”) Cambridge (UK) 10 November 2021: The Company makes the following announcement and notifications in respect of the EU Market Abuse Regulation. NOTIFICATION #11 Details of the person discharging managerial responsibilities / person closely associateda) Name Karen Crews2 Reason for the notificationa) Position/status Senior Executiveb) Initial notification/Amendment Initial notification3 Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitora) Name Hybrid Software Group PLCb) LEI 213800ZFW446QIHAB6544 Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction;...

AC Immune Announces Late-Breaker Presentation by Genentech at CTAD on Phase 2 Lauriet Study of Semorinemab in Mild-to-Moderate Alzheimer’s Disease

Written by Customer Service on November 10, 2021. Posted in Public Companies.

Analysis of the broader mITT population is consistent with the previously reported success in meeting one of the two co-primary endpoints (ADAS-Cog11) with statistically significant reduction in the rate of cognitive decline vs. placebo Benefit of semorinemab on ADAS-Cog11 in all prespecified subgroups was consistent with the treatment effect in the overall cohort, regardless of disease severity, baseline Tau load, and ApoE carrier status Benefit on cognition was driven primarily by the memory domain subcomponent of ADAS-Cog11, a core feature of AD Further analyses evaluating semorinemab’s effects on cerebrospinal fluid (CSF) biomarkers are ongoing as is the open label portion of the study LAUSANNE, Switzerland, Nov. 10, 2021 (GLOBE NEWSWIRE) — AC Immune SA (NASDAQ: ACIU), a clinical-stage biopharmaceutical company pioneering...

Year: 2021

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals